Ridgewood Public Schools Joins National Legal Battle Against “Insulin Pricing Racket”
the staff of the Ridgewood blog
Ridgewood NJ, In a bold move to protect taxpayer funds and employee health benefits, Ridgewood Public Schools has officially entered the ring against the world’s largest pharmaceutical companies and pharmacy benefit managers (PBMs).
Filed on May 20, 2025, the lawsuit (Case No. 2:2025cv04814) accuses a massive roster of defendants—including Eli Lilly, Novo Nordisk, Sanofi, Express Scripts, and CVS Health—of a sophisticated price-fixing scheme that has sent the cost of life-saving insulin skyrocketing.
The Case Explained: What is the “Insulin Pricing Litigation”?
This is not just a standard contract dispute. Ridgewood is suing under the Racketeer Influenced and Corrupt Organizations (RICO) Act, a law typically used to prosecute organized crime.
The core of the allegation: The school district alleges that insulin manufacturers and PBMs (the “middlemen” who negotiate drug prices) conspired to artificially inflate the “sticker price” of insulin. In exchange for pushing certain brands to patients, the PBMs allegedly received massive “rebates” or kickbacks, while the actual cost for self-funded plans—like those managed by school districts—surged by over 1,000% in some cases.
Why Is a School District Suing?
Ridgewood Public Schools, like many government entities, manages its own self-funded health insurance plan. When insulin prices are artificially high, the school district (and the taxpayers who fund it) bears the brunt of the cost.
By joining MDL 3080 (a consolidated Multidistrict Litigation), Ridgewood is part of a growing wave of over 200 school districts, counties, and states nationwide fighting to:
-
Recover millions in overcharged drug costs.
-
Stop the “Kickback” Cycle that rewards middlemen for high prices.
-
Force Transparency in an opaque pharmaceutical market.
Key Players in the Lawsuit
The list of defendants reads like a “Who’s Who” of the healthcare industry:
-
The “Big Three” Manufacturers: Eli Lilly, Novo Nordisk, and Sanofi-Aventis.
-
The PBM Giants: Caremark (CVS), Express Scripts (Cigna), and OptumRx (UnitedHealth).
-
The “Hidden” Entities: Groups like Zinc, Ascent, and Emisar Pharma Services, which plaintiffs claim were used to hide the flow of illegal rebates.
Quick Case Facts
-
Court: U.S. District Court for the District of New Jersey
-
Presiding Judge: Hon. Brian R. Martinotti
-
Nature of Suit: Racketeering (RICO)
-
Latest Update: As of June 23, 2025, the case was reassigned to Magistrate Judge Leda D. Wettre to handle pre-trial proceedings.
Tell your story #TheRidgewoodblog , #Indpendentnews, #information, #advertise, #guestpost, #affiliatemarketing,#NorthJersey, #NJ , #News, #localnews, #bergencounty, #sponsoredpost, #SponsoredContent, #contentplacement , #linkplacement, Email: Onlyonesmallvoice@gmail.com
-
Tags: #RidgewoodNJ #PublicSchools #InsulinLitigation #BigPharma #CVSHealth #EliLilly #RICO #TaxpayerProtection #NJLaw
they should do this with turf fields